Dopamine D3 receptor ligand suppresses the expression of levodopa-induced dyskinesia in nonhuman primate model of parkinson’s disease
Highlights • Dyskinesia is a debilitating side effect of levodopa, the mainstay pharmacotherapy for Parkinson’s disease.• Attenuating dyskinesia has been a significant challenge in the